Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 4446.38 | 459 / 459 | 100% | 31.97 | 1118 / 1118 |
esophagus | 100% | 4013.61 | 1445 / 1445 | 100% | 32.41 | 183 / 183 |
intestine | 100% | 4943.46 | 966 / 966 | 100% | 21.93 | 527 / 527 |
lung | 100% | 5013.52 | 578 / 578 | 100% | 21.61 | 1155 / 1155 |
pancreas | 100% | 3301.31 | 328 / 328 | 100% | 19.65 | 178 / 178 |
prostate | 100% | 4030.10 | 245 / 245 | 100% | 22.80 | 502 / 502 |
bladder | 100% | 4435.38 | 21 / 21 | 100% | 19.43 | 503 / 504 |
ovary | 100% | 4498.95 | 180 / 180 | 100% | 15.31 | 429 / 430 |
thymus | 100% | 5067.19 | 653 / 653 | 100% | 23.89 | 603 / 605 |
stomach | 100% | 3578.50 | 359 / 359 | 100% | 23.27 | 285 / 286 |
uterus | 100% | 4505.20 | 170 / 170 | 100% | 20.03 | 457 / 459 |
brain | 99% | 2799.89 | 2618 / 2642 | 100% | 18.85 | 705 / 705 |
kidney | 100% | 3094.03 | 89 / 89 | 99% | 21.34 | 890 / 901 |
liver | 100% | 2503.92 | 226 / 226 | 99% | 14.89 | 401 / 406 |
adrenal gland | 100% | 4207.93 | 258 / 258 | 99% | 17.20 | 227 / 230 |
skin | 100% | 4349.31 | 1809 / 1809 | 97% | 24.68 | 459 / 472 |
adipose | 100% | 4332.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4183.70 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.24 | 29 / 29 |
muscle | 100% | 4984.88 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5041.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.84 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.91 | 1 / 1 |
peripheral blood | 99% | 5452.56 | 922 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 2828.65 | 846 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 15.40 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050862 | Biological process | positive regulation of T cell receptor signaling pathway |
GO_0016567 | Biological process | protein ubiquitination |
GO_0007283 | Biological process | spermatogenesis |
GO_0071596 | Biological process | ubiquitin-dependent protein catabolic process via the N-end rule pathway |
GO_0007131 | Biological process | reciprocal meiotic recombination |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0031507 | Biological process | heterochromatin formation |
GO_0007141 | Biological process | male meiosis I |
GO_0010526 | Biological process | retrotransposon silencing |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0007140 | Biological process | male meiotic nuclear division |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0071233 | Biological process | cellular response to L-leucine |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0070728 | Molecular function | L-leucine binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0141053 | Molecular function | histone H2A ubiquitin ligase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | UBR2 |
Protein name | E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II) |
Synonyms | C6orf133 KIAA0349 |
Description | FUNCTION: E3 ubiquitin-protein ligase which is a component of the N-end rule pathway . Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation (By similarity). Plays a critical role in chromatin inactivation and chromosome-wide transcriptional silencing during meiosis via ubiquitination of histone H2A (By similarity). Binds leucine and is a negative regulator of the leucine-mTOR signaling pathway, thereby controlling cell growth . Required for spermatogenesis, promotes, with Tex19.1, SPO11-dependent recombination foci to accumulate and drive robust homologous chromosome synapsis (By similarity). Polyubiquitinates LINE-1 retrotransposon encoded, LIRE1, which induces degradation, inhibiting LINE-1 retrotransposon mobilization (By similarity). Catalyzes ubiquitination and degradation of the N-terminal part of NLRP1 following NLRP1 activation by pathogens and other damage-associated signals: ubiquitination promotes degradation of the N-terminal part and subsequent release of the cleaved C-terminal part of NLRP1, which polymerizes and forms the NLRP1 inflammasome followed by host cell pyroptosis (By similarity). . |
Accessions | ENST00000372903.6 [Q8IWV8-2] ENST00000372901.2 [Q8IWV8-4] Q8IWV8 ENST00000372899.6 [Q8IWV8-1] |